Telix Pharmaceuticals Limited is a new Australian (unlisted) public company that has been established to develop and commercialize several late-stage oncology assets. Our specialty area is “theranostic” radiopharmaceuticals – agents that are able to simultaneously image and treat cancer patients.
We are currently in “stealth mode” as we are currently closing several transactions. Please come back and check on us again soon. Feel free to contact us at email@example.com.